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Abstract
Background:  Gene set analysis is considered to be a way of improving our biological
interpretation of the observed expression patterns. This paper describes different methods applied
to analyse expression data from a chicken DNA microarray dataset.
Results: Applying different gene set analyses to the chicken expression data led to different ranking
of the Gene Ontology terms tested. A method for prediction of possible annotations was applied.
Conclusion: Biological interpretation based on gene set analyses dependent on the statistical
method used. Methods for predicting the possible annotations for genes with unknown function
from the expression data at hand could be useful, but our results indicate that careful validation of
the predictions is needed.
Background
A major challenge in large-scale gene expression studies is
the biological interpretation of the observed expression
patterns. Gene set analysis identifies expression changes
in functionally related genes and it is considered to be a
way of improving understanding of the underlying biol-
ogy [1]. Gene sets can be defined based on prior biological
knowledge on gene functions available from public avail-
able databases (e.g. Gene Ontology (GO)) [2]. The aim of
this work was to compare different gene set analyses
methods when applied to a chicken microarray data set.
As a high number of probes on the chicken microarray
lack annotation we also applied a method to predict the
possible annotations from the expression data.
Methods
The data – host reactions in broilers after a secondary 
challenge
The data originated from a microarray experiment con-
ducted to study the host reactions in broilers shortly after
a secondary challenge. The broilers were initially inocu-
lated with phosphate buffered saline (P) or with E.
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maxima (M) followed by a secondary with PBS (P), E.
maxima (M) or with E. acervulina (A), forming five chal-
lenge groups PP, PM, PA, MM and MA. Samples of the
jejunum were collected 8 and 24 hours after the second
challenge and gene expression profiles were obtained
using chicken whole genome oligonucleotide microar-
rays. The result of the contrasts between MM8-PM8,
MM8-MA8 and MM8-MM24 were provided for this work-
shop. A more detailed description of the experiment can
be found in an adjacent paper [3]Hedegaard et al: "Meth-
ods for interpreting lists of affected genes obtained in a
DNA microarray experiment".
Gene Ontology class prediction
GO class predictions for genes with unknown GO annota-
tions were based on expression ratios and support vector
machine (SVM). SVM is a set of machine learning meth-
ods that can be used for data classification and has been
implemented in Gist 2.3 version [4,5] that we have used
in this study. The predictions were focused on signifi-
cantly differentially expressed genes in the contrasts MM8-
MA8, MM8-MM24 and MM8-PM8, defined as the probes
with p-values at or below 0.05 after correcting for multiple
testing by Benjamin and Hochberg's False Discovery Rate
method (FDR) [6]. The total number of oligonucleotides
representing differentially expressed genes was deter-
mined to be 2347. Gist requires expression ratio matrices
without missing values, therefore the number of oligonu-
cleotides were reduced to 936. Of these oligonucleotides,
280 oligonucleotides have previously been mapped to a
GO Biological Process (BP) term. The expression ratios for
these 280 oligonucleotides were defined as the training
set. The test set for class prediction consisted of the expres-
sion ratios for the remaining 656 oligonucleotides with-
out GO BP annotations.
Defining gene sets for gene set analysis
Gene set analyses is based on the available annotation for
the chicken genome. According to EADGENE Oligo Set
Annotation Files [7] version 2 from 11th of September
2008, there are 20460 unique oligonucleotides on the
chicken array. Among these 14592 oligonucleotides rep-
resent 11532 Ensembl chicken genes. There are 2420
Ensembl chicken genes represented by multiple (2 to 9)
oligonucleotides on the array.
Each of the gene lists for the three contrasts (MM8-MM24,
MM8-MA8 and MM8-PM8) [4] contains 13158 oligonu-
cleotides, of which 13126 are unique. The remaining 32
oligonucleotides are multiple copies of control probes.
The oligonucleotides in the gene list were mapped to GO
annotation with 3422 oligonucleotides associated with
(BP), 4385 associated with molecular function (MF) and
3455 associated with cellular component (CC).
Gene sets were defined based on the annotated oligonu-
cleotidesand gene sets with fewer than 5 oligonucleotides
were excluded. There were originally 2553 BP, 1436 MF
and 481 CC terms represented on the array. Applying the
above criteria of gene set definition and filtering reduced
this to 475 BP, 248 MF and 157 CC terms available for the
analysis.
Since a unique gene can be represented by multiple differ-
ent probes on a microarray, it is of interest to compare the
gene set tests based on individual oligonucleotides (oligo-
wise) or on individual genes (gene-wise).
Gene set analysis methods and software
Gene set analysis was performed using software packages
developed in Bioconductor [8] and R [9]. The tests used
were the Wilcoxon test as implemented in the LIMMA
package (version 2.14.5 [10,11]), Fisher's exact test [12]
and Kolmogorov Smirnoff implemented in the topGO
(version 1.8.1. [13]), and Globaltest [14,15] implemented
in the Globaltest package (version 4.12.0). For the Fisher's
exact test a predefined adjusted p-value of 0.05 was cho-
sen to be the cutoff for individual oligonucleotides to be
differentially expressed. Except for the Globaltest, the
result of statistical hypothesis testing (t-statistics or p-
value) for the oligonucleotides was used as input data for
the gene set analyses. The Globaltest uses the expression
data directly when testing gene sets and the corresponding
p-values were computed using either the asymptotic dis-
tribution or permutations [14]. The gene set testing was
done both with and without adjusting the p-values for
multiple testing using FDR [6]. A two-sided binomial test
was used to assess if the p-values from gene-wise and
probe-wise gene set tests tended to be smaller in one case
or another.
Results and discussion
Class prediction for genes with unknown GO annotations
We generated an expression ratio data set with 936 oligo-
nucleotides for genes without missing expression values.
These oligonucleotides were differentially expressed with
false discovery rate at 0.05 in one or more of the contrasts
(MM8-MM24, MM8-MA8 and MM8-PM8). From previ-
ous annotation, 280 oligonucleotides mapped to 467 GO
BP terms and 656 oligonucleotides did not map to any
GO BP term. We characterized two sets, one as a training
set and one as a test set respectively. For each GO term in
the training set it was predicted whether any of the oligo-
nucleotides in the test set could be classified as belonging
to the GO BP term based on similarity in expression pro-
files between the two sets across the tissue samples (MA8,
MM8, MM24 and PM8).
In total, 301 out of 656 oligonucleotides were predicted to
104 GO BP terms with a discriminant value given by GistBMC Proceedings 2009, 3(Suppl 4):S8 http://www.biomedcentral.com/1753-6561/3/S4/S8
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above 1. Additional file 1 shows the top 20 predictions
based on ranking the number of oligonucleotides for each
GO BP term. For most GO BP terms the number of pre-
dicted oligonucleotides is higher than the number of oli-
gonucleotides that was previously mapped. Additional
file 2 shows an example of class prediction for the GO
term 'immune response' (GO:0006955) visualized by
hierarchical clustering of the expression ratios for genes
previously known to map to this GO BP term and genes
that were predicted to belong to this GO term. Validation
of the prediction method using this GO BP term was
attempted using the following approach. Each oligonucle-
otides with previously known mapping to this term was
taken out one by one and tested whether class prediction
classified it to the expected term. Unfortunately, valida-
tion was only possible for oligonucleotides ID
RIGG20020 with the combination of tissue expression
data and prediction method used in this study. The class
prediction approach used in this study was inspired by a
previous study in mice [5]. In comparison to our study,
they used a much higher number of different annotated
GO terms and a much higher number of different tissues,
which may explain the low validation success that we
observed here.
Adjustment for multiple testing
To adjust for multiple testing we applied FDR to the dif-
ferent gene set tests. After adjustment most methods had
no terms with p-value below 0.05 for all categories of GO
terms, the exception being Globaltest. Except for Global
test the corrected p-values were in most cases close to one
or relatively high. There were even many cases where all p-
values became one or close to one. It was therefore
decided to compare the different gene set methods with-
out adjusting for multiple testing. In our attempt to
account for multiple testing we ignored the structure of
the GO graph. Multiple testing procedures assume that
the tests performed are independent. This assumption is
often violated as the GO terms are not independent to
each other due to hierarchical structure of GO and the
usage of multiple GO terms in the annotation of one gene.
Another problem with most multiple testing adjustments
is that they do not change the ranks and therefore the rel-
ative importance of the different GO terms. Alternatively
it is possible to use an adjustment method that account
for the dependencies. One example could be to use the
focus level procedure [16] even though it is not valid for
all kinds of tests.
Gene set tests based on individual oligonucleotides or 
genes
Since the same gene can be measured by a set of different
oligonucleotides which are very likely to have the identi-
cal annotation, it is of interest to compare the gene set
tests based on individual oligonucleotides (oligo-wise) or
on individual genes (gene-wise). For this comparison we
used the Wilcoxon test which determines if the oligonu-
cleotides/genes in the set is up-regulated (up), down-reg-
ulated (down) or differentially expressed regardless of
direction (mixed). Gene sets were defined based on GO
annotation and we analyzed all three contrasts (MM8-
MM24, MM8-MA8 and MM8-PM8).
We computed the Spearman correlations between the vec-
tors of p-values from Wilcoxon tests based on individual
oligonucleotides or genes. For the Wilcoxon test the direc-
tion was not considered. Each vector was generated in the
gene set test defined by GO class for each contrast. There
was a high correlation (0.84–0.92) between these tests.
Comparing across all gene set tests it appeared that the
gene-wise p-values in general are smaller than the oligo-
wise p-values (smaller in 58% of the cases corresponding
to p = 2.2*10-16 in a binomial two sided test). Figure 1
shows the BP terms tested (up-regulated, down-regulated
or differentially expressed) having a p-value less than 0.01
for the different contrasts. The pattern of BP terms for
gene-wise and oligo-wise tests is very similar across the
Visualization of class predictions for GO BP term 'immune  response' showing expression ratio profiles for both oligonu- cleotides with known mapping to this term (1) and oligonu- cleotides predicted to belong to this term (0) Figure 1
Visualization of class predictions for GO BP term 
'immune response' showing expression ratio profiles 
for both oligonucleotides with known mapping to this 
term (1) and oligonucleotides predicted to belong to 
this term (0). Validation was possible only for oligonucle-
otides ID RIGG20020.BMC Proceedings 2009, 3(Suppl 4):S8 http://www.biomedcentral.com/1753-6561/3/S4/S8
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All the BP gene sets which were tested (up-regulated, down-regulated or differentially expressed) having a p-value less than  0.01 are shown for the different contrasts Figure 2
All the BP gene sets which were tested (up-regulated, down-regulated or differentially expressed) having a p-
value less than 0.01 are shown for the different contrasts. g: stands for gene-wise and p: stands for oligo-wise. 1: differ-
entially expressed BP gene sets from MM8_MM24; 2: differential expressed BP gene sets from MM8_MA8; 3: differentially 
expressed BP gene sets from MM8_PM8; 4: up regulated BP gene sets from MM8_MM24; 5: up regulated BP gene sets from 
MM8_MA8; 6: up regulated BP gene sets from MM8_PM8; 7: down regulated BP gene sets from MM8_MM24; 8: down regu-
lated BP gene sets from MM8_MA8 and 9: down regulated BP gene sets from MM8_PM8.
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different contrasts although there are cases where terms
for only the gene-wise or the oligo-wise test.
For the tests based on individual genes the median value
of the t-statistics from all its corresponding oligonucle-
otides was used. The median value measures the trend of
all its transcripts as a whole and if the different oligonu-
cleotides measure different splice variants using the
median may lead to biased results. Alternatively, the t-sta-
tistic for a single oligonucleotides could be used to repre-
sent the gene in the gene set test. Although the results
indicate only minor differences between gene set test
based on individual oligonucleotides or genes it is diffi-
cult to generalize to other datasets. The best choice
depends on the design of the array and in particular if the
number of replicate probes varies for different genes it will
often be better to use tests based on individual genes.
Gene set tests taking GO structure into account
GO has a hierarchical structure that forms a directed acy-
clic graph which leads to a high degree of dependencies
between the tested terms. We used the topGO package
which based on the Fisher's exact test implements two
algorithms (eliminate and weight) that takes the GO
structure into account when testing the gene sets. These
two algorithms were compared to the "classical" Fisher's
exact test and the Kolmogorov Smirnoff test which both
ignores the GO structure. The terms for the three GO cat-
egories were tested for the three contrasts. Figure 2 shows
that taking the GO structure into account leads to fewer
terms with p-value below 0.05 which may indicate
increased specificity as suggested by the authors of the
method [13].
Comparing Globaltest and Wilcoxon test
We also compared the results from the Globaltest and
Wilcoxon test. These methods differ in two important
aspects. First, Wilcoxon test is a competitive test in the
sense that genes in the set are compared to other genes
whereas Globaltest is a self-contained test which generally
leads to higher power [17]. Second Wilcoxon test treats
the individual genes/oligonucleotides as the sampling
units and Globaltest treats the subjects as sampling units
which is a more sound statistical approach. These differ-
ences may in part explain when comparing different
methods the highest ranked terms are not necessarily the
same. We compared the two methods by the number of
common terms among the terms with p-value below 0.05
or among the 15 top ranking terms (Table 1).
The Globaltest gave a much larger number of terms with a
p-value below 0.05. It is however unclear to what extent
this comes at a cost of a higher number of false positives.
For each of the comparisons the terms with p-value below
0.05 given by the Wilcoxon test were almost all found by
the Globaltest (p-value below 0.05). However, only 3 or 4
out of the top 15 terms are overlapping. For the Globaltest
we also found that the number of terms with p-values
below 0.05 to be higher when p-values were computed
using permutation compared to when the asymptotic was
used.
Conclusion
Applying different gene set test to the EADGENE chicken
expression data led to different ranking of the GO terms
tested. Therefore biological interpretation based on gene
set analyses is depending on the statistical method used.
Methods for predicting the possible annotations for genes
with unknown function from the expression data at hand
are useful, but our results indicate that careful validation
of the predictions is needed.
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Table 1: Comparison of Wilcoxon and Globaltest.
Wilcoxon 
(p-value < 0.05)
Global Asymptotic Global Permutation
p-value < 0.05 Common with 
wilcoxon in top 15
Common with 
wilcoxon 
(p-value < 0.05)
p-value < 0.05 Common with 
wilcoxon 
(p-value < 0.05)
MM8_MM24 17 228 3 16 285 17
MM8_MA8 22 215 3 21 264 20
MM8_PM8 30 383 4 30 400 30
For Wilcoxon and Globaltest with the two p-value estimation methods the numbers of terms with p-value below 0.05 are given. The number of 
terms with p-values below 0.05 for each method and overlapping between Wilcoxon and Globaltest are shown as well. For Globaltest with 
Asymptotic p-value calculation the top 15 terms overlapping with the top 15 for Wilcoxon are shown.Publish with BioMed Central    and   every 
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Additional file 1
Top 20 class predictions for GO BP ranked descending by the number 
of predicted oligonucleotides. The table contains the following columns: 
GO ID: GeneOntology Identifier, GO description: GeneOntology descrip-
tion, Oligonucleotide count known: number of oligonucleotides that were 
previously mapped to the GO BP term, Oligonucleotide count predicted: 
number of oligonucleotides that were predicted to belong to the GO BP 
term.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1753-
6561-3-S4-S8-S1.pdf]
Additional file 2
  Visualization of class predictions
GO BP term ‘immune response’ showing expression ratio profiles for 
both oligonucleotides with known mapping to this term (1) and oli-
gonucleotides predicted to belong to this term (0). Validation was pos-
sible only for oligonucleotides ID RIGG20020.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1753-
6561-3-S4-S8-S2.pdf]